Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
C William Schneider Insider Profile
4 Followers
C William Schneider, Director at Northwest Biotherapeutics, holds 2.20M shares in Northwest Biotherapeutics (Ticker: NWBO). Most recently, C William Schneider ― shares of Northwest Biotherapeutics on ― for an estimated value of ―.
C William Schneider has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of C William Schneider's holdings
Insider Roles
Director
Roles that C William Schneider holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by C William Schneider
C William Schneider's Trading History
List of latest transactions for each holding click on a transaction to see C William Schneider's performance on stock
You May Also Like
C William Schneider insider profile FAQ
What is the percentage of profitable transactions made by C William Schneider?
The percentage of profitable transactions made by C William Schneider is ―.
What is the average return per transaction made by C William Schneider?
The average return per transaction made by C William Schneider is ―.
What stocks does C William Schneider hold?
C William Schneider holds: NWBO stocks.
What was C William Schneider’s latest transaction?
C William Schneider latest transaction was an Uninformative Buy of ―.
What was C William Schneider's most profitable transaction?
C William Schneider’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is C William Schneider's role in Northwest Biotherapeutics?
C William Schneider's role in Northwest Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.